AKT1 and neoplasm: Because the inhibition of SHOC2 expression suppresses MAPK but not PI3K activity in tumor cells with RAS gene mutations [30], these observations could partly explain the overactivation of the PI3K pathway in cells treated with HMT, which could contribute to increased phosphorylation of AKT after the inhibition of the SHOC2 complex.